SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($)			3 Months Ended		6 Months Ended
	Feb. 06, 2024	Oct. 02, 2023	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Share based compensation expense					$ 61,040	$ 38,794
Shareholders equity			$ 1,769,867	$ 5,003,998	$ 1,769,867	$ 5,003,998	$ 2,312,852	$ 2,616,261	$ 5,860,087	$ 6,266,427
Stockholders' Equity, Reverse Stock Split	1-for-3
Equity Option [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Options granted				0		0
Options exercised			0	0	0	0
Share based compensation expense			$ 10,000	$ 15,000	$ 61,000	$ 39,000
Unrecognized compensation cost			$ 41,000		$ 41,000
Unrecognized compensation cost weighted average vesting period					6 months
Non Employee Directors [Member] | Equity Option [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Options granted		332,409
Exercise price		$ 0.76
Option grant-date fair value per share		$ 0.36
Fair value of options granted		$ 120,000